Safety, Tolerability, and sensorimotor effect of extended -release 
dalfampridine in adults with cerebral palsy: a pilot study

F Bethoux; A Fatemi; E Fowler; C Marciniak; A Mayadev; J Waksman; K Zackowski; G Suarez; AR Blight; CZ Rabinowcz; E Carrazana

Safety, Tolerability, and sensorimotor effect of extended -release dalfampridine in adults with cerebral palsy: a pilot study

F Bethoux, A Fatemi, E Fowler, C Marciniak, A Mayadev, J Waksman, K Zackowski, G Suarez, AR Blight, CZ Rabinowcz, E Carrazana

Physical Medicine and Rehabilitation

Research output: Contribution to journal › Article

Original language	English (US)
Pages (from-to)	337-346
Number of pages	10
Journal	Clinical Therapeutics
Volume	39
Issue number	2
State	Published - Feb 2017

Cite this

@article{abdcf36a963c4634ad2f58df2923f9d2,

title = "Safety, Tolerability, and sensorimotor effect of extended -release dalfampridine in adults with cerebral palsy: a pilot study",

author = "F Bethoux and A Fatemi and E Fowler and C Marciniak and A Mayadev and J Waksman and K Zackowski and G Suarez and AR Blight and CZ Rabinowcz and E Carrazana",

year = "2017",

month = feb,

language = "English (US)",

volume = "39",

pages = "337--346",

journal = "Clinical Therapeutics",

number = "2",

}

Safety, Tolerability, and sensorimotor effect of extended -release dalfampridine in adults with cerebral palsy: a pilot study. / Bethoux, F; Fatemi, A; Fowler, E; Marciniak, C; Mayadev, A; Waksman, J; Zackowski, K; Suarez, G; Blight, AR; Rabinowcz, CZ; Carrazana, E.

In: Clinical Therapeutics, Vol. 39, No. 2, 02.2017, p. 337-346.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Safety, Tolerability, and sensorimotor effect of extended -release dalfampridine in adults with cerebral palsy: a pilot study

AU - Bethoux, F

AU - Fatemi, A

AU - Fowler, E

AU - Marciniak, C

AU - Mayadev, A

AU - Waksman, J

AU - Zackowski, K

AU - Suarez, G

AU - Blight, AR

AU - Rabinowcz, CZ

AU - Carrazana, E

PY - 2017/2

Y1 - 2017/2

M3 - Article

VL - 39

SP - 337

EP - 346

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 2

ER -